We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

233 hedge funds and large institutions have $1.25B invested in iShares US Medical Devices ETF in 2018 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 89 increasing their positions, 59 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

569% more call options, than puts

Call options by funds: $9.47M | Put options by funds: $1.42M

51% more repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 59

16% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 44

2% more funds holding

Funds holding: 228233 (+5)

27% less capital invested

Capital invested by funds: $1.71B → $1.25B (-$466M)

27% less funds holding in top 10

Funds holding in top 10: 118 (-3)

41.7% less ownership

Funds ownership: 322.85%281.15% (-42%)

Holders
233
Holders Change
+5
Holders Change %
+2.19%
% of All Funds
5.19%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.18%
New
51
Increased
89
Reduced
59
Closed
44
Calls
$9.47M
Puts
$1.42M
Net Calls
+$8.06M
Net Calls Change
+$293M
Name Holding Trade Value Shares
Change
Change in
Stake
SC
101
Scotia Capital
Ontario, Canada
$987K +$180K +5,208 +21%
WCM
102
Weatherstone Capital Management
Colorado
$960K +$243K +7,026 +32%
AIA
103
Armor Investment Advisors
North Carolina
$929K +$66.5K +1,920 +7%
RFC
104
Regions Financial Corp
Alabama
$906K -$52.6K -1,518 -5%
VC
105
Vicus Capital
Pennsylvania
$901K -$90K -2,598 -9%
Prudential Financial
106
Prudential Financial
New Jersey
$845K +$372K +10,752 +74%
SPIA
107
Steward Partners Investment Advisory
New York
$817K -$2.29K -66 -0.3%
CIC
108
Carnegie Investment Counsel
Ohio
$802K -$494K -14,280 -37%
Fidelity Investments
109
Fidelity Investments
Massachusetts
$767K +$67.1K +1,938 +9%
W
110
WealthOne
New York
$763K +$793K +22,908 New
CG
111
Colony Group
Massachusetts
$755K +$785K +22,680 New
TSWM
112
Triangle Securities Wealth Management
North Carolina
$713K -$1.66K -48 -0.2%
FAAS
113
First Allied Advisory Services
California
$681K -$831 -24 -0.1%
Carson Wealth (CWM LLC)
114
Carson Wealth (CWM LLC)
Nebraska
$680K +$277K +8,010 +64%
WB
115
WesBanco Bank
West Virginia
$673K
P
116
&Partners
Tennessee
$651K +$677K +19,560 New
CS
117
Comerica Securities
Michigan
$646K +$672K +19,398 New
CB
118
Commerce Bank
Missouri
$640K -$10.4K -300 -2%
GIA
119
Gladstone Institutional Advisory
Florida
$636K +$662K +19,110 New
ST
120
Spinnaker Trust
Maine
$618K
CWM
121
Cornerstone Wealth Management
Missouri
$612K -$10.5M -302,700 -94%
GCA
122
Genesee Capital Advisors
New York
$601K +$625K +18,036 New
VAM
123
Visionary Asset Management
Texas
$595K +$618K +17,856 New
MWM
124
Mascoma Wealth Management
New Hampshire
$592K -$8.73K -252 -1%
WDL
125
Well Done LLC
Michigan
$591K +$8.31K +240 +1%

IHI Hedge Fund Activity: Q4 2018 in Review

233 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q4 2018, worth a combined $1.25B — down 27% from $1.71B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new IHI positions and 44 closed out — a net gain of 7 holders — while 89 added to existing stakes and 59 trimmed.

The largest buyer was Discovery Capital Management, opening a new position worth an estimated $31.5M. The largest seller was Bank of Montreal, cutting an estimated $148M.

  • 233 institutional investors held iShares US Medical Devices ETF (IHI) as of Q4 2018, up from 228 in Q3 2018.
  • Funds reported $1.25B of iShares US Medical Devices ETF stock for Q4 2018, down 27% quarter-over-quarter.
  • 51 funds opened new iShares US Medical Devices ETF positions in Q4 2018 and 44 closed out, a net change of +7 holders.
  • The largest iShares US Medical Devices ETF buyer in Q4 2018 was Discovery Capital Management, an estimated $31.5M added.
  • The largest iShares US Medical Devices ETF seller in Q4 2018 was Bank of Montreal, an estimated $148M sold.

Based on aggregated 13F filings for Q4 2018.